Hypha LabsFUNI Quick Ratio is 0.07 as of Mar. 2026, which is 85% below its 10-year median of 0.47. The stock has 2 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Hypha Labs ranks worse than 96.74% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Hypha Labs's quick ratio for the quarter that ended in Mar. 2026 was 0.07.
Hypha Labs has a quick ratio of 0.07. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Hypha Labs's Quick Ratio or its related term are showing as below:
FUNI'
s Quick Ratio Range Over the Past 10 Years
Min: 0.07 Med: 0.47 Max: 6.05
Current: 0.07
During the past 13 years, Hypha Labs's highest Quick Ratio was 6.05. The lowest was 0.07. And the median was 0.47.
FUNI's Quick Ratio is ranked worse than 96.74% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.67
vs FUNI: 0.07
Hypha Labs (OTCPK:FUNI) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Hypha Labs Quick Ratio Related Terms
Hypha Labs Quick Ratio Historical Data
* Premium members only.
The historical data trend for Hypha Labs's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Hypha Labs's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hypha Labs Quick Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Hypha Labs's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Hypha Labs's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Hypha Labs's Quick Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hypha Labs (FUNI) has a Quick Ratio of 0.07 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Hypha Labs and its competitors. This is 85% below median its historical median of 0.47. Over the past decade, Hypha Labs' Quick Ratio has ranged from 0.07 to 6.05. According to the industry distribution chart, Hypha Labs ranks #208 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 96.7%.
Is Hypha Labs' Quick Ratio too high?
Hypha Labs' current Quick Ratio of 0.07 is 85% below median its 10-year median of 0.47. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 6.05. The Medical Diagnostics & Research industry median Quick Ratio is 1.67. Hypha Labs' value of 0.07 is 95.8% below this industry median. Based on the distribution chart, Hypha Labs ranks #208 out of 215 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Hypha Labs' Quick Ratio compare to IVRO and IDTA?
According to the Medical Diagnostics & Research industry distribution chart, Hypha Labs ranks #208 out of 215 companies for Quick Ratio. This places Hypha Labs in the lower half of its industry. The industry median Quick Ratio is 1.67. Hypha Labs' value of 0.07 is 95.8% below this benchmark. Historically, Hypha Labs' own Quick Ratio has ranged from 0.07 to 6.05 over the past decade. While the company's 10-year median is 0.47 vs. the industry median of 1.67, Hypha Labs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.67, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hypha Labs's current Quick Ratio of 0.07 is 95.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Hypha Labs and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypha Labs's current Quick Ratio is 0.07, which is 85% below median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypha Labs stock overvalued right now?
Hypha Labs (FUNI) has a current Quick Ratio of 0.07. The current Quick Ratio is 0.07, which is 85% below median its 10-year median of 0.47 and 95.8% below the Medical Diagnostics & Research industry median of 1.67. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Hypha Labs (FUNI), the current Quick Ratio is 0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hypha Labs Inc engaged in the research, development, and commercialization of the Hypha Micropearl accelerator, an in-home, web-based, computer-controlled bioreactor designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company's easy-to-use device, together with replaceable cartridges ordered through its exclusive app, safely and effectively produced enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contained active mushroom ingredients in a concentrated, easy-to-handle, tasteless, and odorless form that could be incorporated into various foods and beverages without altering flavor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FUNI has been successfully added to your 